Pulsed intravenous methylprednisolone therapy for inflammatory myopathies: Evaluation of the effect by comparing two consecutive biopsies from the same muscle

Journal of Neuroimmunology

Volumn 76, Issue 1-2, 1997, Pages 75-80

  Matsubara, S ^a   Hirai, S ^a   Sawa, Y ^b  

^a TOKYO METROPOLITAN NEUROLOGICAL HOSPITAL   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION   (Japan)

Author keywords

ICAM 1; Major histocompatibility complex; Methylprednisolone; Myositis; STAT 1

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; MAJOR HISTOCOMPATIBILITY ANTIGEN; METHYLPREDNISOLONE SODIUM SUCCINATE; PREDNISOLONE; STAT1 PROTEIN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CASE REPORT; CELL INFILTRATION; CONTROLLED STUDY; DERMATOMYOSITIS; FEMALE; HUMAN; HUMAN TISSUE; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MUSCLE REGENERATION; ORAL DRUG ADMINISTRATION; POLYMYOSITIS; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ADULT; AGED; BIOPSY; DERMATOMYOSITIS; DNA-BINDING PROTEINS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; METHYLPREDNISOLONE; MUSCLES; POLYMYOSITIS; STAT1 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS;

EID: 0031005529     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00033-7     Document Type: Article

References (21)

1. Arahata, K. and Engel, A.G. (1984) Monoclonal antibody analysis of mononucleated cells in myopathies. I. Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and count of muscle fibers invaded by T-cells. Ann. Neurol. 16, 193-208.
2. Auphan, N., DiDonato, J.A., Rosette, C., Helmberg, A. and Karin, M. (1995) Immunosuppression by glucocorticoids. Inhibition of NF-κB activity through induction of IκB synthesis. Science 270, 286-290.
3. Carpenter, S. and Karpati, G. (1984) Pathology of Skeletal Muscle. Churchill Livingstone, New York, pp. 663-666.
4. Dalakas, M.C., Illa, I., Dambrosia, J.M., Soueidan, S.A., Stein, D.P., Otero, C., Dinsmore, S.T. and McCrosky, S. (1993) A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N. Engl. J. Med. 329, 1993-2000.
5. Emslie-Smith, A.M., Arahata, K. and Engel, A.G. (1989) Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes and T-cell-mediated cytotoxicity in myopathies. Hum. Pathol. 20, 224-231.
6. Emslie-Smith, A.M. and Engel, A.G. (1990) Microvascular changes in early and advanced dermatomyositis. A quantitative study. Ann. Neurol. 27, 343-356.
7. Engel, A.G. and Arahata, K. (1984) Monoclonal antibody analysis of mononuclear cells in myopathies. II. Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis. Ann. Neurol. 16, 209-215.
8. Horvath, C.M. and Darnell, J.E. Jr. (1996) The antiviral state induced by alpha interferon and gamma interferon requires transcriptionally active STAT1 protein. J. Virol. 70, 647-650.
9. Illa, I. and Dalakas, M.C. (1996) Upregulation of STAT-1 and cytokine activity in the muscles of patients with sporadic inclusion-body myositis but not in hereditary inclusion-body myositis. Neurology 46 (Suppl.) A487.
10. Lindberg, C., Oldfors, A. and Tarkowski, A. (1995) Local T-cell proliferation and differentiation in inflammatory myopathies. Scand. J. Immunol. 41, 421-426.
11. Lundberg, I., Brengman, J.M. and Engel, A.G. (1995) Analysis of cytokine expression in muscle in inflammatory myopathies, Duchenne dystrophy and non-weak controls. J. Neuroimmunol. 63, 9-16.
12. Matsubara, S. and Mair, W.G.P. (1979) Ultrastructural changes in polymyositis. Brain 102, 701-725.
13. Matsubara, S., Takamori, M., Adachi, H. and Kida, H. (1990) Acute toxoplasma myositis. An immunohistochemical and ultrastructural study. Acta. Neuropathol. 81, 223-227.
14. Matsubara, S., Sawa, Y., Takamori, M., Yokoyama, H. and Kida, H. (1994) Pulsed intravenous methylprednisolone combined with oral steroid therapy as the initial treatment of inflammatory myopathies. J. Neurol. Neurosurg. Psychiatry 57, 1008.
15. Metzinger, L., Passaquin, A.C., Warter, J.M. and Poindron, P. (1993) Alpha-methylprednisolone promotes skeletal myogenesis in dystrophin-deficient and control mouse cultures. Neurosci. Lett. 155, 171-174.
16. Miike, T., Tamari, H., Ohtani, Y., Nakamura, H., Matsuda, I. and Miyoshino, S. (1983) A fluorescent microscopy study of biopsied muscles from infantile neuromuscular disorders. Acta Neuropathol. 59, 48-52.
17. Scheinman, R.I., Cogswell, P.C., Lofquist, A.K. and Baldwin, A.S. Jr. (1995) Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science 270, 283-286.
18. Seiner, S.J., Schramm, W. and Keyes, P.L. (1992) Effect of treatment with methylprednisolone on duration of pseudopregnancy and on macrophages and T-lymphocytes in rabbit corpora lutea. J. Reprod. Fertil. 96, 347-353.
19. Staunton, D.E., Martin, S.D., Stratowa, C., Dustin, M.L. and Springer, T.A. (1988) Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families. Cell 52, 925-933.
20. Takeda, T., Nakajima, K., Kojima, H. and Hirano, T. (1994) E1A repression of IL-6-induced gene activation by blocking the assembly of IL-6 response element binding complexes. J. Immunol. 153,4573-4582.
21. Tews, D.S. and Goebel, H.H. (1995) Expression of cell adhesion molecules in inflammatory myopathies. J. Neuroimmunol. 59, 185-194.